EpiCypher, Inc.
Epigenetics is driving discoveries in the treatment and understanding of hematological diseases. EpiCypher is a world-leading developer of innovative research products and services to advance the science of epigenetic regulation and improve human health. From genomic mapping to high-throughput drug screening, our CUTANA™ CUT&RUN/CUT&Tag epigenomic mapping assays and comprehensive class of nucleosome substrates and enzymes provide the tools you need to take your project to the next level.
- Industries
-
Biotechnology
Medical Pharmaceuticals
Pharmaceuticals
- Contact Information
-
Media Contact:
Leslie Lewis - [email protected]
Latest
Journalists and Bloggers
The news you need, when you need it.
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.
LEARN MORE